INTRODUCTION
Human immunodeficiency virus (HIV) infection has historically been an absolute contraindication to kidney transplantation (KT). Since the introduction of potent combined antiretroviral therapies (cARTs), the survival of HIV-infected kidney transplant recipients has dramatically improved.
However, despite the improved survival, the mortality from non-HIV-related events, such as malignancies and chronic diseases including end-stage renal disease (ESRD), has increased [1] . HIV is a chronic and manageable disease in many patients with well-controlled viral replication [2] .
Consequently, chronic conditions such as ESRD have become an important concern in HIV treatment. Numerous studies have shown favorable outcomes after KT in HIV-infected patients, with similar patient and graft survival between HIV-positive and HIV-negative recipients [3, 4] . We present two cases with an approximate follow-up of 5 years after KT. To our knowledge, this is the first report of successful KT in HIV-infected recipients living in South Korea. This case report discusses some of the challenges encountered to provide insights into transplantation in HIV-positive recipients. In this paper, we present a detailed report of two cases and provide a short review of the existing literature. years after transplantation, the SCr levels ranged from approximately 1.3 to 1.5 mg/dL ( Fig. 1 ).
Case 2
A 41-year-old man was followed up for chronic glomer- (Fig. 2) . However, many centers follow the candidate selection criteria established by the National Institutes of Health (NIH) multicenter trials [13, 14] . The NIH criteria specify that candidates must have an undetectable viral load and a CD4 T-cell count of ＞200 cells/mm 3 
DISCUSSION

